Sertraline Hydrochloride Tablet
Product Images NDC 43602-979

This text is a description of Sertraline Hydrochloride Tablets, a medication used to treat depression, anxiety, and other mood disorders. Each film-coated tablet contains 1119 mg sertraline hydrochloride, equivalent to 100 mg sertraline. The medication guide should be provided separately to each patient by the pharmacist. There are 500 tablets in the package. Dosage and use information can be found in the accompanying prescribing information. The medication should be stored at 20°C to 25°C (68°F to 77°F) and is manufactured by Ascent Pharmaceuticals, Inc in Central Islip, NY.*

This is a description of Sertraline Hydrochloride tablets, USP with 15mg dosage. The medicine comes in film-coated tables containing 28mg of Sertraline Hydrochloride which is equivalent to 25mg of sertraline. The package has 500 tablets with a Rev number of 06120 and NDC number of 43602-979-16. The medication should be dispensed with the medication guide provided separately to each patient. The prescription is only to be given by pharmacists. The instructions for dosage and usage are provided in the prescribing information. The medicine should be stored in USP controlled room temperature between 20°C to 25°C (68°F to 77°F). The manufacturer is Ascent Pharmaceuticals, Inc located in Central Tslip, NY 11722.*

This is a medication information for Sertraline Hydrochloride Tablets. Each film-coated tablet contains 56 mg of Sertraline Hydrochloride which is equivalent to 50 mg of Sertraline. It's available in a bottle of 500 tablets and pharmacists are advised to dispense the medication guide provided separately to each patient. The dosage and usage should be based on the accompanying prescribing information. It should be stored in a controlled room temperature of 20°C to 25°C (68°F to 77°F). This medication is manufactured by Ascent Pharmaceuticals, Inc in Central Islip, NY 11723.*

This text appears to be a list of potential symptoms and side effects that may be associated with certain medical conditions or medications. These may include issues such as nausea, loss of appetite, changes in sleep habits, sexual problems, tremors or shaking, and feelings of fatigue or agitation. It is important to always consult with a qualified healthcare provider if you are experiencing any concerning symptoms or side effects.*

This text appears to be a list of medical conditions or histories that may affect a person's health. It includes liver problems, kidney problems, a history of stroke, heart problems, seizures or convulsions, high blood pressure, bipolar disorder or mania, low sodium levels in the blood, and bleeding problems. This information could be useful for healthcare providers determining the best course of treatment for a patient with a relevant medical condition or history.*

This text describes some symptoms related to a medical condition or disease. The symptoms include high fever, uncontrolled muscle spasms, stiff muscles, rapid changes in heart rate or blood pressure, confusion, and loss of consciousness. It is not clear what the specific medical condition is, but it may be serious and require medical attention.*

This is not available as the text contains only chemical symbols and abbreviations without any context.*

This text describes potential warning signs of suicidal thoughts or mental health issues, such as acting aggressive or violent, increased agitation or irritability, trouble sleeping, and new or worsening depression, anxiety or panic attacks. It also mentions dangerous impulses and unusual changes in behavior as potential red flags to seek help.*

This text appears to be a list of symptoms that could indicate a serious medical condition. The symptoms include changes in mental status such as agitation, hallucinations, or coma, as well as nausea, vomiting, and diarrhea. Other symptoms listed include a racing heartbeat, high or low blood pressure, sweating or fever, coordination problems or muscle twitching, and muscle rigidity. It is important to seek medical attention if experiencing any of these symptoms.*

This text describes symptoms of mania, which is a mental health condition characterized by episodes of elevated, expansive or irritable mood, and is often accompanied by symptoms such as increased energy, trouble sleeping, racing thoughts, reckless behavior, and grandiosity. It is important to seek professional help if experiencing these symptoms, as they can be disruptive to daily life and have negative consequences if left untreated.*

This text describes some symptoms that may be associated with a headache, including weakness, feeling unsteady, confusion, problems concentrating or thinking, or memory problems. These symptoms may be helpful for individuals trying to identify the cause of their headache or decide when to seek medical attention.*

The text describes a table showing the recommended daily dosage of Sertraline Hydrochloride for patients with various conditions like MDD, OCD, PD, PTSD, and SAD for both adult and pediatric patients. The starting dose and the therapeutic range for each condition are provided in the table.*

This is a table showing the risk differences in the number of cases of suicidal thoughts or behaviors in placebo-controlled trials of antidepressants in both pediatric and adult patients. The table provides information on the drug-placebo differences in the number of patients per 1000 patients treated, and how this varies according to the age range. The results show that in patients under 18, there were 14 additional patients with suicidal thoughts or behaviors for every 1000 patients treated, compared to placebo. In the 18-24 and 25-64 age ranges, there were 5 and fewer patients respectively. However, in patients above 65, there were 6 fewer patients with suicidal thoughts or behaviors for every 1000 patients treated compared to placebo.*

This is a table showing common adverse reactions in adults with various mental health disorders who were involved in pooled placebo-controlled clinical trials. The table includes the number of patients in each group and the percentage of patients who experienced each adverse reaction while taking sertraline hydrochloride or placebo. The adverse reactions are divided into categories such as cardiac disorders, eye disorders, gastrointestinal disorders, etc. The table also specifies adverse reactions that occurred significantly more frequently in patients taking sertraline hydrochloride compared to those taking placebo.*

Table 4 provides the most common sexual adverse reactions (>2% and twice placebo) in men or women from sertraline hydrochloride pooled controlled trials in adults with MDD, OCD, PD, PTSD, SAD, and PMDD. The table shows the percentage of patients experiencing sexual adverse reactions such as ejaculation failure, libido decreased, erectile dysfunction, ejaculation disorder, and male sexual dysfunction. In men, the percentage ranges from 2% to 8%, whereas in women, it is between 2% to 4%.*

Table 5 provides a list of drugs that have clinically significant interactions with Sertraline Hydrochloride. It mentions drugs that potentiate the risk of serotonin syndrome by increasing the levels of serotonin in the body, drugs that interfere with hemostasis, drugs highly bound to plasma protein and other drugs that prolong the QT interval. With each drug category, the possible intervention and examples of drugs are also provided.*

This text appears to be a list of various mental health disorders or conditions, including Major Depressive Disorder, Obsessive Compulsive Disorder, Panic Disorder, Posttraumatic Stress Disorder, Social Anxiety Disorder, and Premenstrual Dysphoric Disorder.*